SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-18-010733
Filing Date
2018-10-02
Accepted
2018-10-02 08:00:23
Documents
18
Period of Report
2018-10-02
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cbmg_8k.htm 8-K 24691
2 PRESENTATION cbmg_ex991.htm EX-99.1 25325
3 IMAGE cbmgcorporatepresentatio000.jpg GRAPHIC 33563
4 IMAGE cbmgcorporatepresentatio001.jpg GRAPHIC 67866
5 IMAGE cbmgcorporatepresentatio002.jpg GRAPHIC 33770
6 IMAGE cbmgcorporatepresentatio003.jpg GRAPHIC 45425
7 IMAGE cbmgcorporatepresentatio004.jpg GRAPHIC 38062
8 IMAGE cbmgcorporatepresentatio005.jpg GRAPHIC 35685
9 IMAGE cbmgcorporatepresentatio006.jpg GRAPHIC 36570
10 IMAGE cbmgcorporatepresentatio007.jpg GRAPHIC 35019
11 IMAGE cbmgcorporatepresentatio008.jpg GRAPHIC 40455
12 IMAGE cbmgcorporatepresentatio009.jpg GRAPHIC 38006
13 IMAGE cbmgcorporatepresentatio010.jpg GRAPHIC 40721
14 IMAGE cbmgcorporatepresentatio011.jpg GRAPHIC 41022
15 IMAGE cbmgcorporatepresentatio012.jpg GRAPHIC 36597
16 IMAGE cbmgcorporatepresentatio013.jpg GRAPHIC 37690
17 IMAGE cbmgcorporatepresentatio014.jpg GRAPHIC 23122
18 IMAGE cbmgcorporatepresentatio015.jpg GRAPHIC 25453
  Complete submission text file 0001654954-18-010733.txt   892763
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36498 | Film No.: 181099330
SIC: 2836 Biological Products, (No Diagnostic Substances)